Invasight

company

About

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
Fr4.50M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

The company was founded in 2019 and is headquartered in Zurich, Switzerland.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr4.50M
Invasight has raised a total of Fr4.50M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2022 Seed Fr4.50M 2 JFG Life Sciences Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Invasight is funded by 2 investors. JFG Life Sciences Foundation and Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
JFG Life Sciences Foundation Yes Seed
Verve Ventures Seed